Abbott Laboratories buy Benchmark Co.
Start price
10.10.25
/
50%
€115.06
Target price
10.10.26
€125.35
Performance (%)
-7.20%
Price
07:31
€106.78
Summary
This prediction is currently active. With a performance of -7.20%, the BUY prediction by Benchmark_Co_ is trending in the wrong direction. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.609% | -3.609% |
| iShares Core DAX® | 0.760% | 1.149% |
| iShares Nasdaq 100 | 0.732% | 1.884% |
| iShares Nikkei 225® | 1.025% | -0.865% |
| iShares S&P 500 | -0.036% | 1.480% |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat